Notably, previous studies have linked NRF1 inactivation to the development of nonalcoholic steatohepatitis [33], while YY1 upregulation has been associated with fatty liver diseases [17], whereas E2F4 was found to promote HCC proliferation [37,38]. The gene discussed is E2F4; the disease is hepatocellular carcinoma.